Neugalin 75 mg (Capsule)
Unit Price: ৳ 18.45 (3 x 10: ৳ 553.50)
Strip Price: ৳ 184.50
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Acme laboratories ltd |
| Also available as |
Title
- Neugalin 75 mg Capsule
Categories
- Pain Relief
- Neuropathic Pain Management
- Anticonvulsant
Description
- Neugalin is indicated for neuropathic pain associated with diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), adjunctive therapy for the treatment of partial-onset seizures, fibromyalgia, and neuropathic pain associated with spinal cord injury.
Color options
- White
Dimensions
- Standard pharmaceutical capsule size
Functions
- Management of neuropathic pain
- Treatment of partial-onset seizures
- Fibromyalgia management
- Management of postherpetic neuralgia
- Adjuvant for neuropathic pain associated with spinal cord injury
Materials
- Active ingredient: Pregabalin
Technical specifications
- Molecular Formula: C8H17NO2
- Maximum recommended dose: 100 mg three times a day
Design elements
- Capsule form
- CR tablet form
- Chemical Structure: C8H17NO2
Usability features
- Oral administration
- Swallow whole
- Gradual tapering when discontinuing
Dosage recommendation
- Start at 50 mg three times a day (150 mg/day) for DPN, increase to 300 mg/day within 1 week based on efficacy and tolerability
- For PHN, start at 75 to 150 mg two times a day, increase to 300 mg/day within 1 week based on efficacy
- For fibromyalgia, recommended dose of 300 to 450 mg/day, start at 75 mg two times a day (150 mg/day)
Route of administration
- Oral
- Can be taken with or without food
Contraindications
- Hypersensitivity to Pregabalin or any of its components
Side effects
- Dizziness
- Somnolence
- Dry mouth
- Edema
- Blurred vision
- Weight gain
- Difficulty with concentration/attention
- Increased weight and increased appetite in pediatric patients
Pregnancy and lactation
- Potential risk to a fetus, Small amounts detected in the milk of lactating women, Breastfeeding not recommended during treatment
Precautions and warnings
- Angioedema
- Hypersensitivity reactions
- Increased risk of suicidal thoughts or behavior
- Respiratory depression
- Drowsiness and impairment of ability to drive or operate machinery
- Peripheral edema
- Caution when coadministering with thiazolidinedione antidiabetic agents
Special populations
- Safety and effectiveness not established in pediatric patients for certain indications
- Safety and effectiveness not established for pediatric patients below 1 month of age for adjunctive therapy for partial onset seizures
- Safety and effectiveness not established for Neugalin extended-release tablet in pediatric patients
Overdose effects
- Reduced consciousness
- Depression/anxiety
- Agitation and restlessness
- Seizures
- Heart block
- General supportive care indicated
Drug interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
Storage conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Therapeutic class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs